Frequently Asked Questions
The market is segmented based on , By Cell Type (Embryonic Stem Cells, Adult Stem Cell, Induced Pluripotent Cells, Others), Application (Cardiovascular Diseases, Neurological Disorders, Diabetes, Oncology, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Personalized Cell Therapeutic Market size was valued at USD 915.65 USD Million in 2022.
The Global Personalized Cell Therapeutic Market is projected to grow at a CAGR of 24% during the forecast period of 2023 to 2030.
The major players operating in the market include AbbVie ,Bausch Health Companies ,Teva Pharmaceutical Industries Ltd,Cipla ,Lupin,Sun Pharmaceuticals Industries Ltd,Hikma Pharmaceuticals PLC,AstraZeneca,GSK Plc,Pfizer ,Amneal Pharmaceuticals LLC,Alvogen,F. Hoffmann-La Roche Ltd,Amgen ,Jazz Pharmaceuticals,Amicus Therapeutics,MeiraGTx Limited,Rocket Pharmaceuticals,Gilead Sciences, .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
